Welcome to LookChem.com Sign In|Join Free
  • or
2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is a pyridine derivative that features a boronic ester group and a propoxy substituent. This chemical compound is known for its unique reactivity and selectivity in chemical reactions due to the presence of boron, and the pyridine ring enhances its potential as a ligand in various catalytic and coordination processes.

1257553-85-7

Post Buying Request

1257553-85-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1257553-85-7 Usage

Uses

Used in Organic Synthesis:
2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is used as a building block in organic synthesis for the creation of complex organic molecules. Its boronic ester functionality allows for versatile reactions, facilitating the formation of new carbon-carbon and carbon-heteroatom bonds.
Used in Materials Science:
In the field of materials science, 2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is utilized for the development of new materials with specific properties. Its structural features contribute to the design of materials with tailored characteristics for various applications.
Used in Organic Optoelectronics:
2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is used as a component in the design and synthesis of organic optoelectronic devices. Its electronic properties, influenced by the pyridine ring and boronic ester, make it suitable for applications such as organic light-emitting diodes (OLEDs) and organic photovoltaics (OPVs).
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is employed as a synthetic intermediate for the development of new drugs. Its unique chemical properties allow for the creation of bioactive molecules with potential therapeutic applications.
Used in Transition Metal-Catalyzed Reactions:
2-propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine is used as a ligand in transition metal-catalyzed reactions, enhancing the efficiency and selectivity of these processes. Its coordination chemistry with boron compounds contributes to the advancement of catalytic systems in organic synthesis.

Check Digit Verification of cas no

The CAS Registry Mumber 1257553-85-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,7,5,5 and 3 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1257553-85:
(9*1)+(8*2)+(7*5)+(6*7)+(5*5)+(4*5)+(3*3)+(2*8)+(1*5)=177
177 % 10 = 7
So 1257553-85-7 is a valid CAS Registry Number.

1257553-85-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Propoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

1.2 Other means of identification

Product number -
Other names 2-propxy-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1257553-85-7 SDS

1257553-85-7Upstream product

1257553-85-7Downstream Products

1257553-85-7Relevant academic research and scientific papers

ALKYNE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS

-

Page/Page column 76; 77; 86; 87; 110, (2016/05/02)

Provided are compounds of formula (Ia) and pharmaceutically acceptable salts thereof, wherein A, B, R 1, R 2, m and n are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES

-

Page/Page column 160, (2010/12/29)

The invention relates to the use of 1H-imidazo[4,5-c]quinolinone derivatives and salts thereof in the treatment of protein and/or lipid kinase dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases; 1H-imidazo[4,5-c] quinolinone derivatives for use in the treatment of protein and/or lipid kinase dependent diseases; a method of treatment against said diseases, comprising administering the 1H- imidazo[4,5-c] quinofinone derivatives to a warm-blooded animal, especially a human; pharmaceutical preparations comprising an 1H-imidazo[4,5-c] quinolinone derivative, especially for the treatment of a protein and/or lipid kinase dependent disease; novel 1 H- imidazo[4,5-c] quinolinone derivatives; and a process for the preparation of the novel 1H- imidazo[4,5-c] quinolinone derivatives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1257553-85-7